High-flow nasal cannula can't be considered non-inferior to noninvasive ventilation in patients with chronic obstructive pulmonary disease who develop respiratory failure after extubation
Open Access
- 23 November 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-3
- https://doi.org/10.1186/s13054-020-03363-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trialCritical Care, 2020
- High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical TrialAnnals of Emergency Medicine, 2018
- Challenges in the Design and Interpretation of Noninferiority TrialsThe New England Journal of Medicine, 2017
- Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk PatientsJAMA, 2016
- High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic SurgeryJAMA, 2015
- High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory FailureThe New England Journal of Medicine, 2015
- Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failurePublished by Wiley ,2010
- Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialThe Lancet, 2005
- Noninvasive Positive-Pressure Ventilation for Respiratory Failure after ExtubationThe New England Journal of Medicine, 2004